Recent Quotes (30 days)

You have no recent quotes
chg | %

Shire PLC news

   Watch this stock
Showing stories 1 - 10 of about 114   

Articles published

SHP 5,530.00 +5.00 (0.09%)
price chart
Shire PLC 11.8% Potential Upside Indicated by Berenberg
Shire PLC using EPIC code LON:SHP had its stock rating noted as 'Retains' with the recommendation being set at 'BUY' today by analysts at Berenberg.
Shire PLC PT Lowered to GBX 6200 at Berenberg Bank (SHP)  Dakota Financial News
Goldman Sachs Reiterated Shire Plc (LON:SHP)'s Buy Rating
Which is Your Best Pharma Bet: GlaxoSmithKline plc, AstraZeneca plc Or Shire PLC?
The mantra of expand and diversify seems to have gone rather out of fashion since the global financial crisis and recession. These days the rallying cry is: concentration and focus.
Shire plc (SHPG) Misses Q2 EPS by 18c; Updates on Outlook
Shire plc (NASDAQ: SHPG) reported Q2 EPS of $2.63, $0.18 worse than the analyst estimate of $2.81. Revenue for the quarter came in at $1.56 billion versus the consensus estimate of $1.59 billion.
Shire plc (SHPG) Announces Significant Data from Long-Term Vyvanse Efficacy Study
Shire plc (NASDAQ: SHPG) reported positive top-line results from a 39-week, long-term maintenance of efficacy study of Vyvanse (lisdexamfetamine dimesylate) Capsules (CII) in adults with moderate to severe Binge Eating Disorder (B.
Shire Sees Positive Top-Line Study For Vyvanse In Binge Eating  London South East
Shire PLC (SHPG) - Investment Analysts' Recent Ratings Updates
7/22/2015 - Shire PLC had its price target raised by analysts at Cowen and Company from $285.00 to $325.00. They now have an “outperform” rating on the stock.
Company Shares of Shire plc Drops by -1.97%  OTC Outlook
Mid-Day Changers: Biogen Inc. (BIIB), Shire plc (SHPG), ProShares UltraPro ...  WallStreet Scope
As AstraZeneca plc Slumps, Should You Sell And Buy Shire PLC?
Shire's growth is exploding, and investors are clamouring to get their hands on the company's shares. Excluding exceptional items, the company delivered earnings growth of 38% last year.
Shire Plc (SHPG) Earnings Report: Q2 2015 Conference Call Transcript
You should all have received our press release and should be viewing our presentation via our website on If you are unable to access the press release on our website please contact Souheil Salah on our investor relations team at +44 1256 894 ...
Should You Invest In AstraZeneca plc, Shire PLC And Abcam Plc?  Yahoo Finance UK
Shire PLC (SHPG) to Release Earnings on Thursday  Dakota Financial News
Is SkyePharma PLC A Better Buy Than Shire PLC Or Hikma Pharmaceuticals Plc?
The gains haven't been equal, though. Investors in SkyePharma can rightfully feel smug, as their company has risen by 370% since June 2013, compared to 104% for Hikma and 165% for Shire. The only problem is that SkyePharma shares are down by 17% ...
HSBC initiates coverage of European pharmaceuticals Astra, GSK, Hikma and Shire  DIGITALLOOK
Pharma Showdown: Should You Buy GlaxoSmithKline plc Or Shire PLC?
If you're struggling to choose between GlaxoSmithKline (LSE: GSK) and Shire (LSE: SHP), you're not alone. Glaxo and Shire are two of the UK's premier pharmaceutical companies, with their individual strengths and weaknesses. And choosing between the ...
“Buy High, Sell Higher”: A Look At Shire plc, ITV plc, Sirius Minerals plc ...
Market timing can be one of the most important aspects to consider when investing. “Buy low, sell high” is widely considered as the most simple rule to investing.